COVID-19(2) SARS-CoV-2(2) decrease(1) Immunosup-pressed(1) inhibited(1) lung(1) airway(1) patients with COVID-19(1) low dose(1) Lung inflammation(1) SARS-CoV-2-infected cells(1) benefit(1) Infection(1) evaluate(1) therapy(1) sustained(1) virus(1) viral replication(1) protective effect(1) EPO(1) offer(1) Methacholine(1) Inflammation(1) treated(1) animal model(1) BAL(1) SARS-CoV-2-infected cell(1) AhR(1) Vero(1) type II pneumocytes(1)